Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds
- 1 August 2017
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Interventions
Abstract
Background—: A comparison in acute thrombogenicity between the Magmaris sirolimus-eluting bioabsorbable magnesium scaffold and the Absorb bioresorbable vascular scaffold has not been performed. This study assessed acute thrombogenicity of Magmaris compared with Absorb and the Orsiro hybrid drug-eluting stent in a porcine arteriovenous shunt model. Methods and Results—: An ex vivo porcine carotid jugular arteriovenous shunt was established and connected to SYLGARD tubing containing the Magmaris, Absorb, and Orsiro scaffolds/stents and allowed to run in the shunt for a maximum of 1 hour. Twelve shunts (2 shunt runs per pig) were run comparing the 3 scaffolds in alternating order. Nested generalized linear mixed models were used to compare variables between scaffold groups while adjusting for variability between shunt runs. Confocal fluorescent microscopy costaining CD61/CD42b demonstrated that both Magmaris (3.0%) and Orsiro (4.6%) had less platelet coverage of the total scaffold compared with Absorb (21.8%). Scanning electron microscopy demonstrated significantly less thrombus deposition to Magmaris as a percentage of the total scaffold compared with Absorb (5.0% versus 16.1%, P =0.02). Magmaris had significantly less PM-1–positive neutrophil and CD14-positive monocyte adherence compared with both Orsiro and Absorb. Orsiro had significantly less monocyte deposition compared with Absorb. Conclusions—: Despite a similar scaffold strut thickness, the Magmaris sirolimus-eluting bioabsorbable magnesium scaffold was significantly less thrombogenic compared with the Absorb bioresorbable vascular scaffold in an ex vivo porcine arteriovenous shunt model. Further studies are needed to determine whether the reduced thrombogenicity of Magmaris will result in reductions in major cardiovascular events.Keywords
This publication has 24 references indexed in Scilit:
- Impact of Strut Width in Periprocedural Myocardial InfarctionJACC: Cardiovascular Interventions, 2015
- Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting StentCirculation: Cardiovascular Interventions, 2015
- The Effects of Novel, Bioresorbable Scaffolds on Coronary Vascular PathophysiologyJournal of Cardiovascular Translational Research, 2014
- Macro- and microscale variables regulate stent haemodynamics, fibrin deposition and thrombomodulin expressionJournal of The Royal Society Interface, 2014
- Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in HumansCirculation, 2014
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug CoatingsCirculation, 2011
- Characterisation and reproducibility of a human ex vivo model of thrombosisThrombosis Research, 2010
- A method to develop mock arteries suitable for cell seeding and in-vitro cell culture experimentsJournal of the Mechanical Behavior of Biomedical Materials, 2010
- Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatingsBiomaterials, 2010
- Reduced thrombogenicity of nitinol stents—In vitro evaluation of different surface modifications and coatingsBiomaterials, 2006